Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Disposition to Issuer of 8,967,383 shares, $44.84M.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Arbutus Biopharma Corp | Disposition to Issuer | 8,967,383 | $44.84M |
| Dec 12, 2025 | Immunovant, Inc. (IMVT) | Purchase | 16,666,666 | $350.00M |
| Jan 15, 2025 | Immunovant, Inc. (IMVT) | Purchase | 16,845,010 | $336.90M |
| Oct 4, 2023 | Immunovant, Inc. (IMVT) | Grant/Award | 4,473,684 | $170.00M |
| Oct 7, 2022 | Immunovant, Inc. (IMVT) | Purchase | 416,667 | $2.50M |
| Oct 20, 2021 | Arbutus Biopharma Corp (ABUS) | Conversion | 22,833,922 | n/a |
| Aug 3, 2021 | Immunovant, Inc. (IMVT) | Other (see footnotes) | 17,021,276 | n/a |
| Sep 18, 2020 | Immunovant, Inc. (IMVT) | Other (see footnotes) | 8,773,969 | n/a |
| Sep 4, 2020 | Immunovant, Inc. (IMVT) | Purchase | 380,000 | $12.54M |
| May 14, 2020 | Immunovant, Inc. (IMVT) | Other (see footnotes) | 8,773,969 | n/a |